Transaction DateRecipientSharesTypePriceValue
28th February 2020Alberto R Jr Martinez5,000Open or private purchase$0.90$4,500.00
25th February 2020Jeffrey Wayne Church47,000Grant/award etc.$1.16$54,520.00
25th February 2020Timothy J Tumminello14,500Grant/award etc.$1.16$16,820.00
25th February 2020Michael H Tardugno155,000Grant/award etc.$1.16$179,800.00
20th November 2019Alberto R Jr Martinez6,000Open or private purchase$1.42$8,520.00
6th November 2019Frederick J. Fritz10,000Open or private purchase$1.39$13,876.00
4th November 2019Alberto R Jr Martinez4,000Open or private purchase$1.61$6,440.00
2nd August 2019Frederick J. Fritz10,000Open or private purchase$1.73$17,300.00
25th July 2019Alberto R Jr Martinez6,000Open or private purchase$1.76$10,560.00
24th July 2019Frederick J. Fritz10,000Open or private purchase$1.73$17,300.00
Celsion
Celsion logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Celsion Corp. engages in the research and development of pharmaceutical products for cancer treatments. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ. It operates through the Celsion and ThermoDox brands.


Ticker: CLSN
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 749647
Employees: 29
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals